Astera Labs (NASDAQ:ALAB - Get Free Report)'s stock had its "buy" rating restated by analysts at Needham & Company LLC in a research note issued on Tuesday,Benzinga reports. They presently have a $140.00 target price on the stock. Needham & Company LLC's target price would suggest a potential upside of 59.58% from the stock's current price.
Several other analysts also recently issued reports on ALAB. Deutsche Bank Aktiengesellschaft boosted their price objective on Astera Labs from $60.00 to $100.00 and gave the stock a "buy" rating in a report on Tuesday, November 5th. Stifel Nicolaus boosted their price objective on Astera Labs from $100.00 to $150.00 and gave the stock a "buy" rating in a report on Monday, January 6th. Barclays boosted their price objective on Astera Labs from $87.00 to $135.00 and gave the stock an "overweight" rating in a report on Friday, January 17th. Craig Hallum boosted their price objective on Astera Labs from $75.00 to $105.00 and gave the stock a "buy" rating in a report on Tuesday, November 5th. Finally, Morgan Stanley cut their price objective on Astera Labs from $142.00 to $114.00 and set an "equal weight" rating on the stock in a report on Tuesday, January 28th. One analyst has rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $115.33.
View Our Latest Analysis on ALAB
Astera Labs Price Performance
Astera Labs stock traded down $0.46 during midday trading on Tuesday, hitting $87.73. The company's stock had a trading volume of 5,261,325 shares, compared to its average volume of 5,532,401. The stock's 50-day moving average price is $120.82 and its 200-day moving average price is $82.93. Astera Labs has a 12 month low of $36.22 and a 12 month high of $147.39.
Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Monday, February 10th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. As a group, sell-side analysts anticipate that Astera Labs will post -0.45 EPS for the current fiscal year.
Insider Activity at Astera Labs
In other news, Director Stefan A. Dyckerhoff sold 197,297 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $90.51, for a total value of $17,857,351.47. Following the completion of the sale, the director now directly owns 6,148 shares of the company's stock, valued at approximately $556,455.48. This represents a 96.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jitendra Mohan sold 171,064 shares of the company's stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $103.53, for a total value of $17,710,255.92. Following the completion of the transaction, the chief executive officer now owns 628,895 shares of the company's stock, valued at $65,109,499.35. The trade was a 21.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 846,452 shares of company stock valued at $86,427,256.
Institutional Trading of Astera Labs
Large investors have recently made changes to their positions in the business. Nebula Research & Development LLC bought a new position in Astera Labs in the fourth quarter valued at about $256,000. Lord Abbett & CO. LLC boosted its holdings in Astera Labs by 318.9% in the fourth quarter. Lord Abbett & CO. LLC now owns 1,818,600 shares of the company's stock valued at $240,873,000 after acquiring an additional 1,384,498 shares during the last quarter. Voya Investment Management LLC boosted its holdings in Astera Labs by 153.0% in the fourth quarter. Voya Investment Management LLC now owns 637,737 shares of the company's stock valued at $84,468,000 after acquiring an additional 385,693 shares during the last quarter. Fuller & Thaler Asset Management Inc. bought a new position in Astera Labs in the fourth quarter valued at about $67,334,000. Finally, Pinebridge Investments L.P. bought a new position in Astera Labs during the fourth quarter worth about $211,000. Institutional investors own 60.47% of the company's stock.
Astera Labs Company Profile
(
Get Free Report)
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
See Also

Before you consider Astera Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.
While Astera Labs currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.